Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Minerva Surgical, Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subject must meet the approved indication for use to be considered for this registry.
You may not be if
All subjects contraindicated for the treatment of the Genesys HTA System per the Directions for Use will be excluded:
1. The subject is pregnant or wants to be pregnant in the future
2. The subject has known or suspected endometrial carcinoma or premalignant change of the endometrium, such as adenomatous hyperplasia
3. The subject has active pelvic inflammatory disease or pyosalpinx
4. The subject has hydrosalpinx
5. The subject in whom a tight cervical seal cannot be established and maintained around the procedure sheath
6. The subject has an anatomical condition (e.g. history of previous classical cesarean section or transmural myomectomy) or pathologic condition (e.g. long term medical therapy) that could lead to weakening of the myometrium
7. The subject has an intrauterine device in place
8. The subject has an active genital or urinary tract infection (e.g. cervicitis, endometritis, vaginitis, cystitis, etc.) at the time of treatment
Clareo Health | Registry Study of Genesys HTA for Treatment of Menorrhagia
